Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Johe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 30, 2020
NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorderKarl K Johe, Gary Kay, Santosh Kumar, et al.
Radiation Research|January 20, 2018
Remediation of Radiation-Induced Cognitive Dysfunction through Oral Administration of the Neuroprotective Compound NSI-189Barrett D Allen, Munjal M Acharya, Celine Lu, et al.
Journal of Diabetes Research|August 15, 2022
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 DiabetesC G Jolivalt, M R Aghanoori, M C Navarro-Diaz, et al.
Molecular Psychiatry|January 11, 2019
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorderG I Papakostas, K Johe, H Hand, et al.
Journal of Neurotrauma|March 3, 2017
Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem CellsMarkus S Spurlock, Aminul I Ahmed, Karla N Rivera, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Stem Cells Translational Medicine|June 27, 2019
Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic StrokeGuangzhu Zhang, Ying Li, James L Reuss, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 30, 2020
NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorderKarl K Johe, Gary Kay, Santosh Kumar, et al.
Radiation Research|January 20, 2018
Remediation of Radiation-Induced Cognitive Dysfunction through Oral Administration of the Neuroprotective Compound NSI-189Barrett D Allen, Munjal M Acharya, Celine Lu, et al.
Journal of Diabetes Research|August 15, 2022
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 DiabetesC G Jolivalt, M R Aghanoori, M C Navarro-Diaz, et al.
Molecular Psychiatry|January 11, 2019
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorderG I Papakostas, K Johe, H Hand, et al.
Journal of Neurotrauma|March 3, 2017
Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem CellsMarkus S Spurlock, Aminul I Ahmed, Karla N Rivera, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Stem Cells Translational Medicine|June 27, 2019
Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic StrokeGuangzhu Zhang, Ying Li, James L Reuss, et al.
Pageof 2